- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Gastroenterology Research and Practice
Volume 2013 (2013), Article ID 570597, 8 pages
Risk of Atherosclerosis and Helicobacter pylori Infection according to CD14 Promotor Polymorphism in Healthy Korean Population
1Department of Family Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, 93-6 Jungbu-daero, Paldal-gu, Suwon 442-723, Republic of Korea
2Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, 93-6 Jungbu-daero, Paldal-gu, Suwon 442-723, Republic of Korea
Received 12 June 2013; Accepted 28 August 2013
Academic Editor: Tun-Chieh Chen
Copyright © 2013 Sung-Goo Kang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- H. W. L. Ziegler-Heitbrock and R. J. Ulevitch, “CD14: cell surface receptor and differentiation marker,” Immunology Today, vol. 14, no. 3, pp. 121–125, 1993.
- J. Danesh and R. Peto, “Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies,” British Medical Journal, vol. 316, no. 7138, pp. 1130–1132, 1998.
- P. M. Ridker, J. Danesh, L. Youngman et al., “A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar U.S. Men,” Annals of Internal Medicine, vol. 135, no. 3, pp. 184–188, 2001.
- S.-W. Jin, S.-H. Her, J.-M. Lee et al., “The association between current Helicobacter pylori infection and coronary artery disease,” Korean Journal of Internal Medicine, vol. 22, no. 3, pp. 152–156, 2007.
- A. F. M. Stone and M. A. Mendall, “Helicobacter pylori is an aetiological factor for ischaemic heart disease: the case in favour,” Digestive and Liver Disease, vol. 32, no. 1, pp. 62–64, 2000.
- P. M. Ridker, M. Cushman, M. J. Stampfer, R. P. Tracy, and C. H. Hennekens, “Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men,” The New England Journal of Medicine, vol. 336, no. 14, pp. 973–979, 1997.
- M. J. Alberts, “Genetic aspects of cerebrovascular disease,” Stroke, vol. 22, no. 2, pp. 276–280, 1991.
- G. Wick, G. Schett, A. Amberger, R. Kleindienst, and Q. Xu, “Is atherosclerosis an immunologically mediated disease?” Immunology Today, vol. 16, no. 1, pp. 27–33, 1995.
- J. T. Kuvin and C. D. Kimmelstiel, “Infectious causes of atherosclerosis,” American Heart Journal, vol. 137, no. 2, pp. 216–226, 1999.
- R. Ross, “Atherosclerosis—an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999.
- L. Chávez-Sánchez, K. Chávez-Rueda, M. V. Legorreta-Haquet, et al., “The activation of CD14, TLR4, and TLR2 by mm LDL induces IL-1β, IL-6, and IL-10 secretion in human monocytes and macrophages,” Lipids in Health and Disease, vol. 9, no. 1, pp. 117–124, 2010.
- S. J. Bielinski, J. L. Hall, J. S. Pankow et al., “Genetic variants in TLR2 and TLR4 are associated with markers of monocyte activation: the atherosclerosis risk in communities MRI study,” Human Genetics, vol. 129, no. 6, pp. 655–662, 2011.
- Y. Liu, T. Imanishi, H. Ikejima et al., “Association between circulating monocyte subsets and in-stent restenosis after coronary stent implantation in patients with ST-elevation myocardial infarction,” Circulation Journal, vol. 74, no. 12, pp. 2585–2591, 2010.
- T. D. LeVan, J. W. Bloom, T. J. Bailey et al., “A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity,” Journal of Immunology, vol. 167, no. 10, pp. 5838–5844, 2001.
- J. A. Hubacek, G. Rothe, J. Pit'ha et al., “C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction,” Circulation, vol. 99, no. 25, pp. 3218–3220, 1999.
- D. Zhao, T. Sun, X. Zhang et al., “Role of CD14 promoter polymorphisms in Helicobacter pylori infection—related gastric carcinoma,” Clinical Cancer Research, vol. 13, no. 8, pp. 2362–2368, 2007.
- M.-S. Wu, T.-Y. Cheng, C.-T. Shun, M.-T. Lin, L.-C. Chen, and J.-T. Lin, “Functional polymorphisms of CD14 and toll-like receptor 4 in Taiwanese Chinese with Helicobacter pylori-related gastric malignancies,” Hepato-Gastroenterology, vol. 53, no. 71, pp. 807–810, 2006.
- F. Andreotti, I. Porto, F. Crea, and A. Maseri, “Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies,” Heart, vol. 87, no. 2, pp. 107–112, 2002.
- V. Rizzello, G. Liuzzo, E. Trabetti et al., “Role of the CD14 C(-260)T promoter polymorphism in determining the first clinical manifestation of coronary artery disease,” Journal of Cardiovascular Medicine, vol. 11, no. 1, pp. 20–25, 2010.
- K. Shimada, K. Miyauchi, H. Mokuno et al., “Promoter polymorphism in the CD14 gene and concentration of soluble CD14 in patients with in-stent restenosis after elective coronary stenting,” International Journal of Cardiology, vol. 94, no. 1, pp. 87–92, 2004.
- R. Y. L. Zee, K. Lindpaintner, B. Struk, C. H. Hennekens, and P. M. Ridker, “A prospective evaluation of the CD14 C(-260)T gene polymorphism and the risk of myocardial infarction,” Atherosclerosis, vol. 154, no. 3, pp. 699–702, 2001.
- M. T. Longobardo, A. B. Cefalù, F. Pezzino et al., “The C(-260)>T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction,” Clinical and Experimental Medicine, vol. 3, no. 3, pp. 161–165, 2003.
- G. L. Hold, C. S. Rabkin, M. D. Gammon et al., “CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations,” European Journal of Cancer Prevention, vol. 18, no. 2, pp. 117–119, 2009.
- T. Kondo, M. Ohno, K. Shimokata et al., “CD14 promoter polymorphism is associated with acute myocardial infarction resulting from insignificant coronary artery stenosis,” Heart, vol. 89, no. 8, pp. 931–932, 2003.
- J. Danesh, R. Collins, and R. Peto, “Chronic infections and coronary heart disease: is there a link?” The Lancet, vol. 350, no. 9075, pp. 430–436, 1997.
- A. Laurila, A. Bloigu, S. Näyhä, J. Hassi, M. Leinonen, and P. Saikku, “Association of Helicobacter pylori infection with elevated serum lipids,” Atherosclerosis, vol. 142, no. 1, pp. 207–210, 1999.
- R. Maya, R. Ori, S. Yinon, et al., “Helicobacter pylori serology in autoimmune diseases—fact or fiction?” Clinical Chemistry and Laboratory Medicine, vol. 51, no. 5, pp. 1075–1082, 2013.
- S. D. Wright, R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison, “CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein,” Science, vol. 249, no. 4975, pp. 1431–1433, 1990.
- M. Guha and N. Mackman, “LPS induction of gene expression in human monocytes,” Cellular Signalling, vol. 13, no. 2, pp. 85–94, 2001.
- K.-E. Eilertsen, J. O. Olsen, J. Brox, and B. Østerud, “Association of the -159 C → T polymorphism in the CD14 promoter with variations in serum lipoproteins in healthy subjects,” Blood Coagulation and Fibrinolysis, vol. 14, no. 7, pp. 663–670, 2003.
- E. Bernardo, D. J. Angiolillo, C. Ramírez et al., “Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery disease,” American Journal of Cardiology, vol. 98, no. 9, pp. 1182–1184, 2006.
- Y. Li, X.-Q. Xiong, P.-A. Zhang, and K.-H. Ming, “Association of C-159T polymorphism in promoter region of CD14 and coronary heart disease,” Chinese Journal of Medical Genetics, vol. 22, no. 6, pp. 687–690, 2005.
- H.-F. Zhang, B.-L. Zhong, W.-L. Zhu et al., “CD14 C-260T gene polymorphism and ischemic heart disease susceptibility: a HuGE review and meta-analysis,” Genetics in Medicine, vol. 11, no. 6, pp. 403–408, 2009.
- W. P. Castelli, “Cholesterol and lipids in the risk of coronary artery disease. The Framingham Heart Study,” Canadian Journal of Cardiology, vol. 4, supplement A, pp. 5A–10A, 1988.
- N. Sarwar, J. Danesh, G. Eiriksdottir et al., “Triglycerides and the risk of coronary heart disease: 10 158 Incident cases among 262 525 participants in 29 Western prospective studies,” Circulation, vol. 115, no. 4, pp. 450–458, 2007.
- H. B. Rubins, S. J. Robins, D. Collins, et al., “for the secondary prevention of coronary heart disease in men with low levels of high density lipoprotein cholesterol: veterans affairs high-density lipoprotein cholesterol intervention trial study group,” The New England Journal of Medicine, vol. 341, no. 6, pp. 10–18, 1999.
- B. A. Griffin, D. J. Freeman, G. W. Tait et al., “Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk,” Atherosclerosis, vol. 106, no. 2, pp. 241–253, 1994.
- J. Auer, R. Berent, T. Weber, E. Lassnig, and B. Eber, “Thyroid function is associated with presence and severity of coronary atherosclerosis,” Clinical Cardiology, vol. 26, no. 12, pp. 569–573, 2003.
- K. H. Yun, M. H. Jeong, S. K. Oh et al., “Relationship of thyroid stimulating hormone with coronary atherosclerosis in angina patients,” International Journal of Cardiology, vol. 122, no. 1, pp. 56–60, 2007.
- S. A. Hamed, N. F. Amine, G. M. Galal et al., “Vascular risks and complications in diabetes mellitus: the role of Helicobacter pylori infection,” Journal of Stroke and Cerebrovascular Diseases, vol. 17, no. 2, pp. 86–94, 2008.
- M. Izadi, M. Fazel, and S. H. Sharubandi, “Helicobacter species in the atherosclerotic plaques of patients with coronary artery disease,” Cardiovascular Pathology, vol. 21, no. 4, pp. 307–311, 2012.
- B. Schöttker, M. A. Adamu, M. N. Weck, H. Müller, and H. Brenner, “Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: a population-based cohort study,” Atherosclerosis, vol. 220, no. 2, pp. 569–574, 2012.
- M. Kowalski, “Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific dna in human coronary atherosclerotic plaque,” Journal of Physiology and Pharmacology, vol. 52, supplement 1, pp. 3–31, 2001.